These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8067185)

  • 1. [Plasma serine protease inhibitors in patients with liver cirrhosis].
    Piatkowska M; Kotschy M; Rość D; Wiśniewska E; Opoka J
    Acta Haematol Pol; 1994; 25(2):145-9. PubMed ID: 8067185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
    Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
    Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma serine protease inhibitors in dialyzed patients with chronic renal insufficiency].
    Kotschy M; Kassian J; Lampka M; Rajewski W
    Pol Merkur Lekarski; 1997 Feb; 2(8):93-5. PubMed ID: 9538647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein C and plasma serine protease inhibitors in patients with essential hypertension].
    Kłoczko J; Bielawiec M; Galar M; Czaczkowska T; Wojtukiewicz M
    Pol Tyg Lek; 1991 Dec 26-30; 46(50-52):974-6. PubMed ID: 1669185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
    Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural protease inhibitors to fibrinolysis in liver diseases.
    Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
    Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombin III and alpha 2-antiplasmin in blood of patients operated on for benign prostatic hyperplasia].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):75-6. PubMed ID: 8756735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the mechanism of hyperfibrinolysis in liver cirrhosis--changes of plasma t-PA, PAI-1 and active PAI-1 levels in liver cirrhosis].
    Matsuura R; Soma M; Maeda Y; Kasakura S
    Rinsho Byori; 1995 Dec; 43(12):1256-60. PubMed ID: 8569037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The plasma levels of urokinase plasminogen activator and plasminogen activator inhibitor-1 and the protein expressions of alpha-SMA and MMP-1 and TIMP-1 in patients with different grades of liver fibrosis].
    Bai K; Guo CJ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):459-61. PubMed ID: 16792874
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic efficacy of plasma urokinase-type plasminogen activator and plasminogen activator inhibitor-2 in differentiation of hepatocellular carcinoma from cirrhosis.
    Song KS; Lee A; Choi JR; Kwon OH
    Thromb Haemost; 1995 Sep; 74(3):864-7. PubMed ID: 8571313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
    Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
    Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.